What are Accelerated Approval and Breakthrough Therapy Designations?
The FDA offers special designations to expedite the approval of promising cancer treatments:
Accelerated Approval: Allows earlier approval of drugs that treat serious conditions and fill an unmet medical need based on a surrogate endpoint. Breakthrough Therapy: Designation for drugs showing substantial improvement over existing treatments during early clinical evidence.
